Presence of Banned Drugs in Dietary Supplements Following FDA Recalls

被引:72
|
作者
Cohen, Pieter A. [1 ]
Maller, Gregory [2 ]
DeSouza, Renan [2 ]
Neal-Kababick, James [3 ]
机构
[1] Harvard Univ, Sch Med, Boston, MA USA
[2] Cornell Univ, Ithaca, NY USA
[3] Flora Res Labs, Grants Pass, OR USA
来源
关键词
D O I
10.1001/jama.2014.10308
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:1691 / 1693
页数:3
相关论文
共 50 条
  • [32] FDA has substantial and sufficient authority to regulate dietary supplements
    McNamara, SH
    Siegner, AW
    FOOD AND DRUG LAW JOURNAL, 2002, 57 (01) : 15 - 24
  • [33] Quantity of phenibut in dietary supplements before and after FDA warnings
    Cohen, Pieter A.
    Ellison, Ross R.
    Travis, John C.
    Gaufberg, Slava V.
    Gerona, Roy
    CLINICAL TOXICOLOGY, 2022, 60 (04) : 486 - 488
  • [34] Presence of Piracetam in Cognitive Enhancement Dietary Supplements
    Cohen, Pieter A.
    Zakharevich, Igor
    Gerona, Roy
    JAMA INTERNAL MEDICINE, 2020, 180 (03) : 458 - 459
  • [35] FDA Regulation of Dietary Supplements and Requirements Regarding Adverse Event Reporting
    Frankos, V. H.
    Street, D. A.
    O'Neill, R. K.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2010, 87 (02) : 239 - 244
  • [36] Drugs and dietary supplements with unproven effects in research and practice
    Jargin, Sergei V.
    JOURNAL OF COMPLEMENTARY MEDICINE RESEARCH, 2019, 10 (01): : 27 - 37
  • [37] Dietary Supplements: Which Place between Food and Drugs?
    Feart, Catherine
    NUTRIENTS, 2020, 12 (01)
  • [38] Pharmacokinetic Interactions between Drugs and Botanical Dietary Supplements
    Sprouse, Alyssa A.
    van Breemen, Richard B.
    DRUG METABOLISM AND DISPOSITION, 2016, 44 (02) : 162 - 171
  • [39] CYTOSTATIC DRUGS AND DIETARY SUPPLEMENTS - CLINICALLY RELEVANT INTERACTIONS?
    Farkouh, A.
    Georgopoulos, A.
    Czejka, M.
    ANTICANCER RESEARCH, 2014, 34 (10) : 5900 - 5901
  • [40] Use of dietary supplements and their interactions with prescription drugs in the elderly
    Ly, J
    Percy, L
    Dhanani, S
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2002, 59 (18) : 1759 - 1762